Kazuharu Harada
Papers
1
Total Citations
11
H-Index
1
About
Dr. Kazuharu Harada is a surgical pathologist whose research focuses on refining prognostic markers in prostate cancer, particularly through the lens of histomorphology. His major contribution lies in elucidating the clinical significance of cribriform architecture—a specific growth pattern within Gleason pattern 4 tumors. In his landmark 2024 study, Harada demonstrated that the ratio of cribriform morphology area to total tumor area is a powerful, independent predictor of biochemical recurrence (BCR) following robot-assisted radical prostatectomy. By meticulously quantifying this feature in Gleason score 4+4 patients, he provided a more granular risk stratification tool than traditional grading alone. This work, already garnering 11 citations, addresses a critical gap in urologic pathology: distinguishing which patients with high-grade disease will experience recurrence. Harada’s research bridges surgical pathology and clinical oncology, offering pathologists a reproducible metric to guide adjuvant therapy decisions. His findings underscore the importance of volumetric assessment over simple presence-or-absence reporting, positioning him as a key voice in the ongoing refinement of prostate cancer grading systems.
Research Focus
Key Achievements
Top Papers
- 1